Australian Pancreatic Genome Initiative

Registration Status: Pending

Objective:

The APGI’s ongoing mission is to further develop the resource comprising biospecimens and comprehensive information on pancreatic cancer patients from diagnosis onwards, including clinical, genomic and outcome data and to use this resource to improve pancreatic cancer care in the era of personalised medicine. APGI brings together the expertise of pancreatic cancer scientists and healthcare professionals across Australia, and is dedicated to accelerating the translation of scientific discoveries to improve outcomes for patients.

Registered Biobank Name	Australian Pancreatic Genome Initiative (APGI)
Biobank Leader	Nicola Blackburn
Principal Investigator	Professor Anthony Gill, Professor Paul Timpson
Address	Garvan Institute of Medical Research 370 Victoria St, Darlinghurst Sydney, NSW, Australia
Website	https://www.pancreaticcancer.net.au
Email for biobank inquiries	research@pancreaticcancer.net.au
User Type Mono: A biobank that supports a specific research project, may have few staff members, a small-scale accrual scope with little to no initial intention of releasing or distributing biospecimens to secondary parties Oligo: A biobank that supports several research groups or clinical trials, may or may not be designed to release biospecimens outside their collaborative group Poly: A biobank that has generally a larger accrual scope, resources, and multiple users outside the biobank proper	Poly - Collection aimed at supporting undetermined, multiple users with ethics approved research projects, through a defined access/application mechanism.

Biospecimen Collected: